SK Biopharm has ranked among the top searched stocks on 6 days within the past month.
As of 2:32 PM on the 15th, SK Biopharm is trading at 148,500 KRW, down 2.94% from the previous day. This represents a 15.14% decline compared to September 11.
Today, foreign investors are tentatively recorded as net sellers of 4,000 shares. Over the past 5 days, individual investors have net bought 304,804 shares, while foreign and institutional investors have net bought 115,165 shares and net sold 387,466 shares, respectively.
On October 14, SK Biopharm was a market highlight for its "strong performance on the export of epilepsy drugs to Japan worth 580 billion KRW."
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
